Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
539.00    27.00 (5.27%)
Bid:
538.50
Ask:
539.50
Spread: 1.00 (0.186%)
Market Cap: £1.46b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Contract Award

19 Apr 2018 07:00

RNS Number : 3744L
Chemring Group PLC
19 April 2018
 

FOR IMMEDIATE RELEASE 19 APRIL 2018

 

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

 

 

CONTRACT AWARDS

 

Chemring Group is pleased to announce that the UK Ministry of Defence ("MOD") has now confirmed orders for the next two years totalling approximately £23 million.

 

All contracts are with UK based subsidiaries and are for the supply of countermeasures (£11 million), pyrotechnic products (£8 million) and a range of demolition stores (£4 million).

 

Deliveries under these contracts will be made during the MOD's financial years commencing April 2018 and April 2019.

 

Michael Flowers, Group Chief Executive of Chemring, commented:

 

"We are delighted to receive these awards in support of the UK MOD which further underpin our plans for FY18 and help to build order coverage for FY19.

 

"As the UK MOD seeks to provide the armed forces with the highest level of protection, receipt of these contracts is testament to both the trusted position that Chemring holds with its key domestic customer and the mission-critical nature of our products in protecting the lives of our armed forces.

 

"We look forward to continuing to deliver the highest performing and highest quality products in support of our customers."

 

 

-ENDS-

 

For further information:

 

Rupert Pittman Group Director of Corporate Affairs, 01794 833901

Chemring Group PLC

 

Andrew Jaques MHP Communications 020 3128 8100

James White

 

 

 

 

 

Notes to editors

· Chemring is a global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

· Employing approximately 2,600 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is organised under three strategic product segments: Countermeasures, Sensors, and Energetics

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.co.uk

 

Cautionary statements

This announcement contains unaudited information based on management accounts and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

 

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

 

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

No statement in this announcement is intended as a profit forecast for FY17 and no statement in this announcement should be interpreted to mean that underlying operating profit for the current or future financial years would necessarily be above a minimum level, or match or exceed the historical published underlying operating profit or set a minimum level of underlying operating profit.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFKFDKPBKDAQD
Date   Source Headline
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20253:20 pmRNSHolding(s) in Company - Replacement
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSContract Award
1st Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20252:57 pmRNSHolding(s) in Company
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20251:46 pmRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20257:01 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20254:12 pmRNSHolding(s) in Company
27th Feb 20252:43 pmRNSDirector/PDMR Shareholdings
27th Feb 20258:00 amRNSHolding(s) in Company
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20251:29 pmRNSResult of AGM
26th Feb 20257:00 amRNSAGM Update
25th Feb 20253:50 pmRNSHolding(s) in Company
21st Feb 20252:54 pmRNSHolding(s) in Company
3rd Feb 20257:00 amRNSTotal Voting Rights
27th Jan 20253:59 pmRNSNotice of AGM
14th Jan 20257:00 amRNSRoke Contract Award
2nd Jan 202511:01 amRNSTotal Voting Rights
19th Dec 20247:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.